GALMED PHARMACEUTICALS LTD. Operating Expenses
GALMED PHARMACEUTICALS LTD. (GLMD) reported Operating Expenses of $2.77 million for the 3-month period ending 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. operating expenses for the quarter ending 2026-06-30 was $2.77M, a 31.58% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. operating expenses for the quarter ending 2025-12-31 was $3.04M, a 85.04% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. operating expenses for the quarter ending 2025-09-30 was $2.10M, a 4.18% increase year-over-year.
- GALMED PHARMACEUTICALS LTD. operating expenses for the quarter ending 2025-06-30 was $2.11M, a 72.59% increase year-over-year.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.77M 6-K · filed 2026-09-02 | $4.82M 6-K · filed 2026-09-02 | ||
| 2025-12-31 | $3.04M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $5.14M derived: sum of 2 quarters · filed 2026-03-31 | $7.25M derived: sum of 3 quarters · filed 2026-09-02 | $8.51M 20-F · filed 2026-03-31 |
| 2025-09-30 | $2.10M 6-K · filed 2025-11-26 | $4.20M derived: sum of 2 quarters · filed 2026-09-02 | $5.47M 6-K · filed 2025-11-26 | |
| 2025-06-30 | $2.11M 6-K · filed 2026-09-02 | $3.37M 6-K · filed 2026-09-02 | ||
| 2024-12-31 | $1.64M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $3.65M derived: sum of 2 quarters · filed 2026-03-31 | $4.88M derived: sum of 3 quarters · filed 2026-03-31 | $6.28M 20-F · filed 2026-03-31 |
| 2024-09-30 | $2.01M 6-K · filed 2025-11-26 | $3.23M derived: sum of 2 quarters · filed 2025-11-26 | $4.63M 6-K · filed 2025-11-26 | |
| 2024-06-30 | $1.22M 6-K · filed 2025-08-28 | $2.62M 6-K · filed 2025-08-28 | ||
| 2023-12-31 | $7.49M 20-F · filed 2026-03-31 | |||
| 2023-06-30 | $1.87M 6-K · filed 2024-08-28 | $3.87M 6-K · filed 2024-08-28 | ||
| 2022-12-31 | $17.65M 20-F · filed 2025-04-02 | |||
| 2022-06-30 | $3.73M 6-K · filed 2023-08-09 | $9.82M 6-K · filed 2023-08-09 | ||
| 2021-12-31 | $32.88M 20-F · filed 2024-04-04 | |||
| 2021-06-30 | $8.41M 6-K · filed 2022-08-04 | $17.54M 6-K · filed 2022-08-04 | ||
| 2020-12-31 | $30.21M 20-F · filed 2023-03-29 | |||
| 2020-06-30 | $5.82M 6-K · filed 2021-08-05 | $12.28M 6-K · filed 2021-08-05 | ||
| 2019-12-31 | $22.38M 20-F · filed 2022-05-02 | |||
| 2019-06-30 | $4.70M 6-K · filed 2019-08-05 | $8.74M 6-K · filed 2019-08-05 | ||
| 2018-12-31 | $10.71M 20-F · filed 2019-03-13 | |||
| 2018-06-30 | $2.77M 6-K · filed 2019-08-05 | $5.33M 6-K · filed 2019-08-05 | ||
| 2017-12-31 | $12.36M 20-F · filed 2019-03-13 | |||
| 2017-06-30 | $2.70M 6-K · filed 2018-08-02 | $5.96M 6-K · filed 2018-08-02 | ||
| 2016-12-31 | $16.88M 20-F · filed 2019-03-13 | |||
| 2016-06-30 | $4.22M 6-K · filed 2017-07-31 | $8.32M 6-K · filed 2017-07-31 | ||
| 2015-12-31 | $10.88M 20-F · filed 2018-03-13 | |||
| 2015-06-30 | $2.53M 6-K · filed 2017-06-23 | $5.03M 6-K · filed 2017-06-23 | ||
| 2014-12-31 | $9.14M 20-F · filed 2017-03-23 | |||
| 2013-12-31 | $14.57M 20-F · filed 2016-03-22 | |||
| 2012-12-31 | $3.14M 20-F · filed 2015-03-31 |